Systems and methods for increasing convective clearance of undesired particles in a microfluidic device

Patent metadata

Field	Value
Publication number	US-10603419-B2
Application number	US-201615046152-A
Country	US
Kind code	B2
Filing date	Feb 17, 2016
Priority date	Jan 11, 2013
Publication date	Mar 31, 2020
Grant date	Mar 31, 2020

Abstract

A microfluidic device for increasing convective clearance of particles from a fluid is provided. In some implementations, described herein the microfluidic device includes multiple layers that each define infusate, blood, and filtrate channels. Each of the channels have a pressure profile. The device can also include one or more pressure control features. The pressure control feature controls a difference between the pressure profiles along a length of the device. For example, the pressure control feature can control the difference between the pressure profile of the filtrate channel and the pressure profile of the blood channel. In some implementations, the pressure control feature controls the pressure difference between two channels such that the difference varies along the length of the channels by less than 50% of the pressure difference between the channels at the channels' inlets.

First claim

What is claimed:

1. A microfluidic device comprising:
a first layer defining an infusate channel, the infusate channel having a first pressure profile with a first slope along a length of the infusate channel;
a second layer defining a blood channel in fluidic communication with the infusate channel, the blood channel having a second pressure profile with a second slope along a length of the blood channel;
a filtrate layer defining a filtrate channel in fluidic communication with the blood channel, the filtrate channel having a third pressure profile with a third slope along a length of the filtrate channel;
a first interchannel flow barrier separating the infusate channel and the blood channel, wherein the first interchannel flow barrier includes a plurality of openings defined through the first interchannel flow barrier, allowing passage of fluid from the infusate channel into the blood channel;
a second interchannel flow barrier separating the filtrate channel and the blood channel;
a first controllable flow control device along a length of the filtrate channel configured to actively control the third slope of the third pressure profile along the length of the filtrate channel relative to the second slope of the second pressure profile along the length of the blood channel;
a second controllable flow control device configured to actively control the first slope of the first pressure profile along the length of the infusate channel relative to the second slope of the second pressure profile along the length of the blood channel; and
a control system configured to modify a state of the first controllable flow control device and the second controllable flow control device such that the first slope of the first pressure profile along the length of the infusate channel is substantially parallel to the third slope of the third pressure profile along the length of the filtrate channel.

2. The microfluidic device of claim 1 , further comprising at least one pressure sensor coupled to the control system, wherein the control system is configured to modify the state of the first or second controllable flow control device responsive to an output of the at least one pressure sensor.

3. The microfluidic device of claim 1 , wherein the first and second controllable flow control devices are one of a recirculating pump, a proportional valve, a diaphragm chamber, or an outflow pump.

4. The microfluidic device of claim 1 , wherein the control system is configured to control the first and second controllable flow control devices such that the first pressure profile is substantially parallel to the second pressure profile.

5. The microfluidic device of claim 1 , wherein the control system is configured to cause the first controllable flow control device to achieve a state such that the slope of the third pressure profile is greater than the slope of the second pressure profile.

6. The microfluidic device of claim 1 , wherein the control system is configured to cause the first controllable flow control device to achieve a state such that the slope of the third pressure profile is less than the slope of the second pressure profile.

7. The microfluidic device of claim 1 , comprising a third controllable flow control device configured to, along with the first controllable flow control device, actively control the slope of the third pressure profile along the length of the filtrate channel relative to the slope of the second pressure profile along the length of the blood channel.

8. The microfluidic device of claim 1 , wherein the blood channel has a height in the range of about 50 μm to about 500 μm, a width in the range of about 50 μm to about 900 μm, and a length in the range of about 3 cm to about 30 cm.

9. The microfluidic device of claim 1 , wherein the second interchannel flow barrier comprises a membrane.

10. The microfluidic device of claim 1 , wherein the second interchannel flow barrier is a sterility barrier.

11. The microfluidic device of claim 1 , wherein the first interchannel flow barrier further comprises a membrane located between the infusate channel and the blood channel.

12. The microfluidic device of claim 1 , wherein the second layer defines a plurality of blood channels.

13. The microfluidic device of claim 12 , wherein the plurality of blood channels are in fluid communication with the infusate channel through the plurality of openings in the first interchannel flow barrier.

14. The microfluidic device of claim 13 , wherein the plurality of openings through the first interchannel flow barrier are positioned sequentially along the length of the infusate channel, and each of the openings spans across all of the blood channels in the second layer.

15. The microfluidic device of claim 14 , wherein the openings through the first interchannel flow barrier have a pitch along the length of the infusate channel of between about 1 cm and 10 cm.

16. The microfluidic device of claim 14 , wherein the spacing of the openings through the first interchannel flow barrier decreases along the length of the infusate channel.

17. The microfluidic device of claim 14 , wherein the size of the openings through the first interchannel flow barrier increases along the length of the infusate channel.

18. The microfluidic device of claim 1 , wherein the first interchannel flow barrier comprises a substantially non-porous material through which the openings are defined.

19. The microfluidic device of claim 18 , wherein the first interchannel flow barrier includes a portion of the first layer defining a floor of the infusate channel.

Assignees

• Charles Stark Draper Laboratory Inc
• Johnson & Johnson Innovation LLC
• The Charles Stark Draper Laboratories Inc

Inventors

• Charest Joseph L
• Nohilly Martin
• Dibiasio Christopher
• Borenstein Jeffrey T
• Laurenzi Mark
• Wilson Jonathan

Classifications

• A61M1/34

  Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration · CPC title

• A61M2230/207

  hematocrit · CPC title

• A61M1/1601

  Control or regulation · CPC title

• A61M1/1603 Primary

  Regulation parameters · CPC title

• A61M1/3441

  Substitution rate control as a function of the ultrafiltration rate · CPC title